Meta-Analysishigh evidence
Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis.
Neurology·August 11, 2026·PMID 42467874
Why it mattersClinicians managing generalized myasthenia gravis now have multiple novel therapies without head-to-head comparisons. This analysis provides comparative efficacy and safety estimates across treatment classes, helping guide therapeutic decisions while highlighting that trial population differences may confound indirect comparisons.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled